Drug intelligence / Profile preview

HPR Plus

Development stage: Unknown
Lead developer: PruGen
Modality: Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

HPR Plus is a prescription topical medical device formulated as a white lotion or cream, developed by PruGen for the management of skin conditions including atopic dermatitis and radiation dermatitis. It is classified as a barrier repair treatment that works by providing a physical barrier to protect the skin, maintain a moist environment, and alleviate symptoms such as burning, itching, and pain. In clinical studies involving breast cancer patients, HPR Plus has been evaluated for its prophylactic potential in reducing the severity of radiation-induced skin reactions, although it is primarily recognized for its role in skin barrier maintenance and symptom relief.

Brand names: HPR Plus
Other names: HPR Plus Cream

Beyond the preview

Go deeper on HPR Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HPR Plus.

Explore the full profile